Cambridge Biostability, Lipoxen, Health Protection Agency, University of Cambridge deal

The parties will reformulate vaccines for influenza and undisclosed indications to improve stability, increase shelf-life and reduce dosing. Cambridge Biostability will provide its VitRIS technology t...